Healthcare News and Research

Latest Healthcare News and Research

Maryland startup Rhemisphere signs agreement with UMB for right to commercialize Blink system

Maryland startup Rhemisphere, LLC has licensed a unique, "all-in-one" patient monitoring system invented by clinical researchers at the University of Maryland, Baltimore.

28 Apr 2010

Trade negotiations between EU, India could affect access to low-cost generics

The Associated Press examines the ongoing free-trade negotiations between the EU and India - a country that according to PricewaterhouseCoopers currently "makes one-fifth of the world's generics." The negotiations "could make it harder for millions … across the developing world to get lifesaving drugs. The deal is taking shape as India tries to transform itself from a generics powerhouse into a base for drug discovery - a trend that could ultimately do more than any trade agreement to curtail its reign as a pharmacy to the poor."

28 Apr 2010

FDA issues warning over faulty components in external defibrillators

About 280,000 external defibrillators used worldwide in health care facilities, public places, or in the home may malfunction during attempts to rescue people in sudden cardiac arrest, the U.S. Food and Drug Administration warned today.

28 Apr 2010

Boston-Power announces lithium-ion battery technology for medical device and equipment market

Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.

28 Apr 2010

Discovery Labs reports first-quarter results, updates on Surfaxin and key pipeline programs

Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.

28 Apr 2010

Healthline Networks raises $14M through third round of financing led by IGC

Healthline Networks, the leading provider of intelligent health information services, today announced that it has raised $14 million in a third round of financing led by Investor Growth Capital (IGC), the wholly owned venture capital arm of Investor AB (Investor). The round also includes strategic financing from GE/NBC Universal's Peacock Equity Fund, a joint venture between GE Capital's Media, Communications & Entertainment business and NBC Universal and Reed Elsevier Ventures.

28 Apr 2010

News outlets continue malaria coverage

World Malaria Day was Sunday and news organizations continued to cover local events.

28 Apr 2010

Laughter is truly the best medicine says new research

A new study has shown that laughter may be one of the simplest exercises that has similar effects on the body as pumping iron in the gym. Researchers have named “Laughercise” as significant elevators of mood, stress busters, immunity boosters and blood pressure and cholesterol reducers. It can also stimulate appetite for the malnourished.

28 Apr 2010

Ontario seniors stand against McGuinty government's $750M cuts to front-line healthcare

The Alliance of Seniors/Older Canadians Network, an organization of approximately 20 seniors organizations, representing in excess of 200,000 seniors across Ontario, along with concerned seniors from our communities, have come out today to stand against the McGuinty government's $750M cuts to front-line healthcare.

28 Apr 2010

Moody's report: States will feel pinch of reform's Medicaid, health care expansions

"The Medicaid expansion under health reform is expected to strain state budgets already distressed by the recession, despite delays for new eligibility rules and federal aid, Moody's Investors Service said in a newly released report. States that see the largest gains in Medicaid enrollment under health reform will likely see the greatest financial burden, Moody's said."

28 Apr 2010

Mesa Laboratories announces acquisition of SGM Biotech

Mesa Laboratories, Inc., a Lakewood, Colorado based manufacturer of electronic instruments and disposables, today announced the acquisition of SGM Biotech, Inc., a Montana manufacturer of biological indicator products.

28 Apr 2010

MHS announces completion of $7.0 million Series B equity investment

Management Health Solutions, Inc. (MHS), a leading provider of supply chain management solutions to hospitals and healthcare providers across the United States, announced today the completion of a $7.0 million Series B equity investment led by Enhanced Equity Fund, L.P. (Enhanced Equity). Radius Ventures, LLC (Radius), the company's existing institutional investor, also participated in the financing round.

28 Apr 2010

Gangs increasingly involved in Medicare fraud

ABC News: "Gangs across the country are arming themselves with powerful weapons to bilk taxpayers out of billions of dollars through Medicare fraud. What used to be a mostly non-violent, white collar crime has turned potentially deadly, and Federal agents who once combed through paperwork are now firing rounds at the shooting range to prepare for extreme dangers.

28 Apr 2010

BioMedix TRAKnet software suite receives APMA Seal of Acceptance

Today, the BioMedix TRAKnet software suite was granted the prestigious American Podiatric Medical Association (APMA) Seal of Acceptance. BioMedix is the only company to receive the APMA Seal of Acceptance for Electronic Health Record and Practice Management software.

28 Apr 2010

Salix Pharmaceuticals announces novel patient and health care provider support program for HE

Salix Pharmaceuticals, Ltd. today announced plans for the Hepatic Encephalopathy Living Program (H.E.L.P.). H.E.L.P. is a first-of-its-kind patient and health care provider support program for the management of hepatic encephalopathy (HE) and will launch on May 24, 2010. The program will provide patients with HE educational materials, co-pay assistance, treatment adherence support and a 24-hour toll-free hotline.

27 Apr 2010

IntegraMed America's Vein Clinics business grows 20% in first-quarter 2010

IntegraMed America, Inc., the leader in developing and managing specialty healthcare facilities in the fertility and vein care markets, today announced strong results for the first quarter ended March 31, 2010.

27 Apr 2010

Amedisys' first-quarter 2010 net service revenues up 20.8%

Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.

27 Apr 2010

UK MHRA authorizes Presidio Pharmaceuticals to initiate Phase 1 clinical trial of PPI-461 for HCV

Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.

27 Apr 2010

Centene's first-quarter Premium and Service Revenues up 12.5% to $1.022 billion

Centene Corporation today announced its financial results for the quarter ended March 31, 2010. The results of operations for our New Jersey health plan, University Health Plans, are classified as discontinued operations. The discussions below, with the exception of cash flow information, are in the context of continuing operations and all financial ratios exclude premium taxes.

27 Apr 2010

Medivir rights offering to raise approximately SEK 325 million

The Board of Directors has resolved on the terms for the rights offering, that the Board of Directors on 28 March 2010 resolved, subject to approval by the Annual General Meeting. For every share held in Medivir, regardless of share class, the holder is entitled to one subscription right. Four subscription rights entitle the holder to subscribe for one new class B share.

27 Apr 2010

Healthcare News and Research

Latest Healthcare News and Research

Maryland startup Rhemisphere signs agreement with UMB for right to commercialize Blink system

Trade negotiations between EU, India could affect access to low-cost generics

FDA issues warning over faulty components in external defibrillators

Boston-Power announces lithium-ion battery technology for medical device and equipment market

Discovery Labs reports first-quarter results, updates on Surfaxin and key pipeline programs

Healthline Networks raises $14M through third round of financing led by IGC

News outlets continue malaria coverage

Laughter is truly the best medicine says new research

Ontario seniors stand against McGuinty government's $750M cuts to front-line healthcare

Moody's report: States will feel pinch of reform's Medicaid, health care expansions

Mesa Laboratories announces acquisition of SGM Biotech

MHS announces completion of $7.0 million Series B equity investment

Gangs increasingly involved in Medicare fraud

BioMedix TRAKnet software suite receives APMA Seal of Acceptance

Salix Pharmaceuticals announces novel patient and health care provider support program for HE

IntegraMed America's Vein Clinics business grows 20% in first-quarter 2010

Amedisys' first-quarter 2010 net service revenues up 20.8%

UK MHRA authorizes Presidio Pharmaceuticals to initiate Phase 1 clinical trial of PPI-461 for HCV

Centene's first-quarter Premium and Service Revenues up 12.5% to $1.022 billion

Medivir rights offering to raise approximately SEK 325 million

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in